Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Input: Consider Input: Henry Schein Animal Health announced in a news release Monday that it will begin operations in a 50,000-square-foot facility in Southaven in December. Henry Schein Animal Health offers products and solutions to more than 29,000 veterinary professionals. Gov. Phil Bryant said northern Mississippi’s transportation network and location is advantageous to companies with distribution needs. Henry Schein Animal Health’s North America president, Fran Dirksmeier, says the new distribution center is the result of extensive planning and collaboration with the Mississippi Development Authority. The development authority is providing assistance through the Jobs Tax Credit program, and DeSoto County is providing ad valorem and Free Port Warehouse tax exemptions.

Output: Animal health care company to open Mississippi facility.


Input: Consider Input: That could all change with a controversial Nov. 4 ballot initiative in which voters will get to decide for the first time whether to abolish a 1963 state law designed to protect small businesses. The law requires North Dakota pharmacies to be owned by local pharmacists or run by hospitals with a local pharmacist on staff. Supporters of the initiative argue it will remove an embarrassing anachronism, give consumers more choice and lower prescription drug costs. Opponents say that allowing national chains would destroy North Dakota’s tradition of personalized pharmacy care and be yet another example of how the state’s neighborly way of life is changing too fast. Canada, Germany, France and many other countries, they also note, have similar laws requiring local pharmacy ownership. “Independent pharmacies are more apt to focus on customer service,” said Gabe Gretz, who bought Service Drug Pharmacy in Williston last year with his father. “This is our bread and butter. It’s not just a hobby for us.”  “North Dakota Nice” is a truism here, not an irony, and most retail stores are still prohibited from opening before noon on Sunday - a throwback to laws designed to encourage family time. Yet since the oil boom began around 2010, drawing thousands of new residents to jobs where roughnecks can earn more than $100,000 a year, drug use, assault and other violent crimes have jumped. Recent sex-trafficking charges brought against an oil field worker in Williston, a once quiet town that is now the epicenter of the boom, marked the first charges of that type ever filed in the area and has escalated tension between new and old residents. Many newly arrived oil workers, and even some locals, say they hope the ballot measure passes so that they can use the  same chains they’ve grown accustomed to elsewhere. Rite Aid Corp has no outpost in the state, North Dakota’s Walmarts have no in-store pharmacies and the state’s lone Walgreens, on the Minnesota border, is prohibited from selling prescription drugs. CVS is able to operate only a handful of pharmacies in North Dakota thanks to a 2006 buyout of several Osco Drug stores that operated before the 1963 law. “Honestly, it’s not convenient getting my prescriptions here,” said Jan Anseth, a resident of Williston who spends winters in Arizona where she gets her medications from a national chain. In North Dakota, Anseth says, she runs into problems transferring prescriptions and getting anything more than a 30-day supply. The ballot’s primary sponsor, North Dakotans For Lower Pharmacy Prices, was funded with $168,000 in contributions from Walmart, Walgreens, Kmart and others. In campaign materials, the group cites data the Kaiser Family Foundation compiled in 2009 showing North Dakota has one of the highest per capita costs for prescription drug and medical devices in the country. Walmart says North Dakotans are missing out on its popular $4 prescription program, which makes many generic drugs available at the sharply discounted price. Crying foul, the state’s independent pharmacists say they’re able to often meet or beat prices from national chains, most of whom lose money on pharmacy sales as a way to get customers in the door. A random survey by Reuters of North Dakota’s independent pharmacies showed that a 30-day supply of the generic blood thinning drug clopidogrel ranged in price between $10 and $59.95. A CVS in Bismarck, the state capital, quoted a price of $149.95 for the same dosage. “I get to set the prices here at my pharmacy,” said Jenna Wahlstrom, a pharmacist at Larsen Service Drug, which her grandfather founded in Watford City in 1952. “It’s not a corporate decision.”  Like the big chains, Wahlstrom offers her customers a smartphone app and online refill ordering. Her pharmacy has transferred hundreds of prescriptions from retail chains for workers who have moved to the state, she said. Ahead of the vote, the state’s top politicians are declining to take sides. Governor Jack Dalrymple, a Republican who took office in 2010, says he shops at locally owned Aerohead Plaza Drug while in Bismarck and believes it has been able to compete effectively with the nearby CVS. Yet in the 1990s, as a state legislator, Dalrymple voted to keep the pharmacy law intact. “I don’t know,” he now says, “if that was the right vote.”

Output: Big pharmacies knock on door of oil-rich North Dakota.


Input: Consider Input: Chaiya, under pressure from health activists and doctors who campaigned to have him sacked, said declaring compulsory licenses on the drugs would save Thailand more than 3 billion baht ($100 million) over the next five years. “The findings have convinced me to go ahead with the CLs since the ministry’s policy is to give patients good access to quality drugs at cheap prices,” Chaiya said of the review by a panel of Health Ministry officials. The decision is a blow to major pharmaceutical companies which had lobbied hard to reverse the CL policy launched by the previous government appointed after a bloodless 2006 coup. The three drugs are Letrozole, a breast cancer medicine made by Novartis AG, the breast and lung cancer drug Docetaxel by Sanofi-Aventis, and Roche’s Erlotinib, used for treating lung, pancreatic and ovarian cancer. A license issued on a leukemia drug, Glivec, was cancelled last month after its maker, Novartis, agreed to supply it free to hundreds of Thai patients. Shortly after a democratically-elected government took power in February, Chaiya ordered the review of a policy he said was a “politically correct decision, but not legally correct”. At the time he said the government could afford the full cost of the drugs, if it meant avoiding trade retaliation by the United States, home to some of the world’s biggest drug firms. U.S. officials denied there were any plans to impose sanctions on Bangkok, although Thailand was placed on a watch list, meaning Washington believed its respect for patents had weakened. When Chaiya, a businessman with no medical training, fired the Health Ministry’s top official negotiating cheaper prices from foreign drug firms, outraged health activists and doctors launched a campaign to remove him. Chaiya said on Monday the ministry would buy cheaper versions of the cancer drugs from generic producers, such as Indian firms which already supply copy-cat HIV-AIDS medicines to Thailand. Under World Trade Organisation rules, countries can issue a compulsory license to make or buy generic versions of patented drugs deemed critical to public health as long as the medicines are meant for domestic use. Former Health Minister Mongkol na Songkhla overrode Merck’s AIDS drug Efavirenz in late 2006, arguing that Thailand could not afford patented drugs for a national health plan that covers about 80 percent of the country’s 63 million people. A few months later he did the same on a Sanofi-Aventis heart medicine and an AIDS drug made by Abbott Laboratories, which refused to register several new medicines in Thailand. Mongkol, who targeted the four cancer drugs weeks before he left office, has defended the CL policy against major drug firms which accused him of stealing their intellectual property rights. ($1= 30 Baht)


Output: Thailand will override cancer drug patents.